「ＭＡ」の検索結果
170件：121～125件目を表示
-
General Announcement: May 9, 2024 Senju Pharmaceutical Co., Ltd. Senju announces initiation of Phase III Clinical Trials in Japan for “SJP-0008” for the treatment of Central Retinal Artery Occlusion S
https://www.senju.co.jp/sites/default/files/content_news/2024-05/ENG_20240509.pdf -
General Announcement: September 7, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of “Smart MIEr” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution of
https://www.senju.co.jp/sites/default/files/content_news/2023-09/ENG_20230907.pdf -
IDU_HENKOU1_202405
2024 ೧ 5 ݆ IDUʰιϱζϣʱΝ͕࢘͏ਫ਼๏ ҫ༂నਜ਼࢘༽Ͷ͖ܿͦ͵͏ๅͲͤɽච͕ͥಣΊ͚ͫ͠͏ɽ ʰ࢘༽қʱրఙ͕எΔͦ ౕ͞ɼऀʲIDUʰιϱζϣʱ ʳͶͯ͘Ή͢ͱɼ ʰ࢘༽қʱ͕Γ;ใૹࣁࡒΝԾىΓ͑Ͷ րఙ͏ͪ͢Ήͪ͢ͲɼۚΞͲ͟Ҍ಼ਅ͍͢͝Ήͤɽ ͵͕ɼླྀ௪ࡑށ͖ܐؖΔրఙశชॽΝ෩ͪ͗͢ɼ͕घݫͶ͚ΉͲͶͺऑױ
https://www.senju.co.jp/sites/default/files/content_news/2024-04/IDU_HENKOU1_202405_1.pdf -
General Announcement: November 1, 2023 Senju Pharmaceutical Co., Ltd. Launch of Distribution of the OptiLight M22 IPL Model Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President: Mr. S
https://www.senju.co.jp/sites/default/files/content_news/2023-11/ENG__20231101_0.pdf -
General Announcement: April 23, 2024 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for NAVIS” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distribution
https://www.senju.co.jp/sites/default/files/content_news/2024-04/ENG_20240423_0.pdf